FI952088L - Transformoituja endoteelisoluja - Google Patents

Transformoituja endoteelisoluja Download PDF

Info

Publication number
FI952088L
FI952088L FI952088A FI952088A FI952088L FI 952088 L FI952088 L FI 952088L FI 952088 A FI952088 A FI 952088A FI 952088 A FI952088 A FI 952088A FI 952088 L FI952088 L FI 952088L
Authority
FI
Finland
Prior art keywords
endothelial cells
transformed endothelial
transformed
cells
endothelial
Prior art date
Application number
FI952088A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI952088A7 (fi
FI952088A0 (fi
Inventor
Fritz H Bach
Martin Rainer De
Original Assignee
Sandoz Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ltd filed Critical Sandoz Ltd
Publication of FI952088A7 publication Critical patent/FI952088A7/fi
Publication of FI952088A0 publication Critical patent/FI952088A0/fi
Publication of FI952088L publication Critical patent/FI952088L/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A01K67/0271—Chimeric vertebrates, e.g. comprising exogenous cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Veterinary Medicine (AREA)
  • Environmental Sciences (AREA)
  • Cell Biology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Husbandry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Transplantation (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FI952088A 1992-11-02 1993-10-29 Transformoituja endoteelisoluja FI952088L (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB929222931A GB9222931D0 (en) 1992-11-02 1992-11-02 Organic compounds
PCT/EP1993/003015 WO1994010305A1 (en) 1992-11-02 1993-10-29 Transformed endothelial cells

Publications (3)

Publication Number Publication Date
FI952088A7 FI952088A7 (fi) 1995-05-02
FI952088A0 FI952088A0 (fi) 1995-05-02
FI952088L true FI952088L (fi) 1995-05-02

Family

ID=10724398

Family Applications (1)

Application Number Title Priority Date Filing Date
FI952088A FI952088L (fi) 1992-11-02 1993-10-29 Transformoituja endoteelisoluja

Country Status (16)

Country Link
EP (1) EP0669977B1 (de)
JP (1) JPH08502653A (de)
KR (1) KR950704477A (de)
AT (1) ATE192492T1 (de)
AU (1) AU680636B2 (de)
CA (1) CA2143489A1 (de)
DK (1) DK0669977T3 (de)
ES (1) ES2146235T3 (de)
FI (1) FI952088L (de)
GB (1) GB9222931D0 (de)
GR (1) GR3033600T3 (de)
NO (1) NO951628L (de)
NZ (1) NZ257539A (de)
PT (1) PT669977E (de)
RU (1) RU2164415C2 (de)
WO (1) WO1994010305A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2726005B1 (fr) * 1994-10-10 1997-01-03 Adim Lignees immortalisees de cellules endotheliales cerebrales et leurs applications au traitement de differents troubles ou maladies primaires et secondaires neurologiques ou psychiatriques
JPH11503905A (ja) * 1995-03-24 1999-04-06 ノバルティス・アクチエンゲゼルシャフト 移植および炎症または血栓症状態の遺伝子治療
AU5289596A (en) * 1995-04-13 1996-10-30 Chugai Seiyaku Kabushiki Kaisha Peptide suppressing ixbalpha phosphorylation
JPH0959151A (ja) * 1995-08-24 1997-03-04 Kao Corp NF−κB活性化抑制剤
EP0779361A3 (de) 1995-12-15 1999-11-10 F. Hoffmann-La Roche Ag Verkürzte Form von Kappa B Inhibitor-Protein, rekombinanter Herstellung und Verwendung
JP2000510326A (ja) * 1996-02-14 2000-08-15 ノバルティス アクチエンゲゼルシャフト 移植および炎症状態に対する抗アポトーシス性遺伝子療法
US20010053769A1 (en) 2000-01-21 2001-12-20 Christiane Ferran Use of pro-apoptotic factors in treatment of atherosclerosis
EP1702062A2 (de) * 2003-06-11 2006-09-20 Jan Remmereit Kern-umprogrammierung von zellen für die therapeutische verwendung
TW201120210A (en) 2009-11-05 2011-06-16 Hoffmann La Roche Glycosylated repeat-motif-molecule conjugates
TWI647309B (zh) 2011-04-01 2019-01-11 Chugai Seiyaku Kabushiki Kaisha 重組多肽之製造方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE68910682T2 (de) * 1988-03-01 1994-06-01 Whitehead Biomedical Inst Aktivierung der nf-kappa b-vorstufe.
DE69123981T3 (de) * 1990-10-31 2006-06-14 Cell Genesys Inc Nützliche retrovirale vektoren für die gentherapie

Also Published As

Publication number Publication date
FI952088A7 (fi) 1995-05-02
EP0669977A1 (de) 1995-09-06
CA2143489A1 (en) 1994-05-11
ATE192492T1 (de) 2000-05-15
PT669977E (pt) 2000-08-31
FI952088A0 (fi) 1995-05-02
GR3033600T3 (en) 2000-09-29
NO951628D0 (no) 1995-04-28
AU680636B2 (en) 1997-08-07
EP0669977B1 (de) 2000-05-03
NZ257539A (en) 1996-08-27
JPH08502653A (ja) 1996-03-26
NO951628L (no) 1995-07-03
DK0669977T3 (da) 2000-08-07
RU2164415C2 (ru) 2001-03-27
ES2146235T3 (es) 2000-08-01
AU5440494A (en) 1994-05-24
GB9222931D0 (en) 1992-12-16
KR950704477A (ko) 1995-11-20
WO1994010305A1 (en) 1994-05-11

Similar Documents

Publication Publication Date Title
DE69322573D1 (de) Zellkultureinsatz
DE69319983D1 (de) Zellkultureinsatz
KR930026553U (ko) 배터리 지지용 지지체
FI935768L (fi) I fysiologisk omgivning upploesande mineralfibrer
FI931968L (fi) Foerbaettringar i radiostaempling
NO933118D0 (no) Dyrkningsbeholder for cellekulturer
FI925636A0 (fi) Katod foer anvaendning i en elektrolytisk cell
FI931711A0 (fi) Stoedfot foer kran i kompositmaterial
FI956320L (fi) Kannatinpalkki
FI952088A7 (fi) Transformoituja endoteelisoluja
FI933038A0 (fi) Matningssystem foer presspartiet i en pappermaskin
FI923978L (fi) Effektekonomi i mobilteleapparat
NO941665D0 (no) Kontinuerlig forbakt anodecelle
FI923709L (fi) I en saekerhetsskena laosbar vagn
FI933709L (fi) Haollare foer vaevbladet i en soemvaevmaskin
FI931058A0 (fi) Rakelbalk foer faergningsanordningen i en tryckmaskin
FI935002A7 (fi) Justerbar solvstyranordning foer jacquardmaskinen i en soemvaevstol
DE69326161D1 (de) Solarschalter
DE59302466D1 (de) Lagerung
FI933485A0 (fi) Avrinningsinsats foer montering i existerande avrinningsbassaeng
DE69327415D1 (de) Zellenvermittlungseinrichtung
ATA247692A (de) Stabbatterie
FI925685A0 (fi) Foerfarande i foerbraenningsmotorprocess
DE69408688D1 (de) Energiespeicher - schwungrad
FI922527L (fi) Vaeggkonstruktion foer anordning i byggnader

Legal Events

Date Code Title Description
GB Transfer or assigment of application

Owner name: NOVARTIS AG